Stock listing

gettex:5VB Nykode Therapeutics ASA Aktie

German listing (gettex) of Nykode Therapeutics ASA · home listing Oslo:NYKD

Follow Nykode Therapeutics ASA into a list and get an email when it puts out news.

Home listing price · OSL:NYKD

2.67 NOK -0.08 (-2.7%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OSL:NYKD

Past year +23.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
2.62 – 2.76 NOKNov 20, 2026
Volume
1.15M sharesNov 20, 2026
Market cap
1.04B NOKAt the close on Nov 20, 2026 · price × 391.5M shares outstanding
52-week range
2.06 – 5.20 NOKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
7.67M NOKMedian day 1.04M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Nykode Therapeutics ASA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Oslo:NYKD · Home2.665 NOK-0.075 (-2.7%)1,153,5992.752.7552.622.74Close on Nov 20, 2026
OTC:VACBF$0.297 USD0.000 (0.0%)—$0.297$0.297$0.297$0.297Close on Nov 6, 2026
Stuttgart:5VB€0.233 EUR-0.007 (-2.9%)—€0.238€0.247€0.215€0.240Close on Nov 20, 2026
Frankfurt:5VB€0.211 EUR-0.009 (-3.9%)—€0.211€0.211€0.211€0.219Close on Nov 20, 2026
Munich:5VB€0.322 EUR-0.002 (-0.5%)—€0.322€0.322€0.322€0.323Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OSL:NYKD · NOK, adjusted for splits

DayCloseChange%OpenHighLowVolume
2.665-0.075-2.7%2.752.7552.621,153,599
2.740.000.0%2.802.8152.74574,244
2.74-0.075-2.7%2.812.8252.74806,252
2.815-0.05-1.7%2.882.8852.815344,412
2.865-0.025-0.9%2.892.952.865439,366
2.89-0.07-2.4%3.003.002.89466,321
2.96+0.03+1.0%2.9853.0252.96577,247
2.93-0.045-1.5%2.953.002.891,565,169
2.975-0.015-0.5%3.153.152.975444,557
2.99+0.03+1.0%2.953.042.92684,650
2.96-0.115-3.7%3.163.202.96847,907
3.075+0.085+2.8%2.9453.202.945672,888
2.99+0.08+2.7%2.9053.0152.80811,582
2.91-0.095-3.2%2.9853.022.91649,707
3.005-0.015-0.5%3.003.0752.9451,173,671
3.02-0.04-1.3%3.083.083.015755,085
3.06-0.07-2.2%3.1453.1453.021,550,380
3.130.000.0%3.153.153.10388,339
3.13-0.02-0.6%3.163.193.10343,539
3.15-0.065-2.0%3.1253.213.12863,731
3.215-0.105-3.2%3.283.3453.175769,630
3.32+0.14+4.4%3.183.353.181,089,822
3.18-0.01-0.3%3.2453.2453.11361,457
3.19+0.065+2.1%3.133.203.101,277,181
3.1250.000.0%3.1253.1753.125288,242
3.125-0.055-1.7%3.3353.3353.10421,455
3.18-0.025-0.8%3.233.233.1351,715,845
3.205-0.21-6.1%3.3053.4253.0153,813,154
3.415-0.025-0.7%3.4953.4953.38471,223
3.44+0.04+1.2%3.383.523.38622,472
3.40-0.125-3.5%3.5253.5253.381,096,763
3.525-0.03-0.8%3.523.5653.47499,985
3.555-0.04-1.1%3.613.643.555417,038
3.595+0.12+3.5%3.4553.5953.455494,432
3.475+0.025+0.7%3.503.503.45407,047
3.45-0.12-3.4%3.693.693.411,456,871
3.57-0.02-0.6%3.5853.6453.555893,560
3.59-0.02-0.6%3.633.7253.58881,341
3.61-0.295-7.6%3.553.6753.503,322,565
3.905+0.09+2.4%3.813.953.801,455,737
3.815-0.12-3.0%3.9353.9553.8151,436,951
3.935-0.095-2.4%4.024.0653.935629,340
4.03+0.06+1.5%4.004.1053.985896,598
3.97-0.08-2.0%4.184.183.9551,206,542
4.05+0.03+0.7%4.014.1954.002,143,022
4.02+0.095+2.4%3.914.033.905761,275
3.925+0.115+3.0%3.8753.953.785977,792
3.81-0.05-1.3%3.803.863.7651,221,177
3.86-0.09-2.3%3.923.943.8551,288,557
3.95-0.09-2.2%4.094.103.951,994,420
4.04-0.16-3.8%4.144.214.021,769,194
4.20+0.20+5.0%3.994.2153.931,834,055
4.00-0.025-0.6%4.054.1253.991,713,271
4.025-0.07-1.7%4.054.133.9851,336,844
4.095+0.015+0.4%4.144.144.05997,829
4.08-0.03-0.7%4.1754.204.0551,845,455
4.11+0.035+0.9%4.1154.2854.0854,187,115
4.075-0.215-5.0%4.284.283.995,223,055
4.29-0.01-0.2%4.2754.374.104,990,942
4.30-0.69-13.8%4.564.6654.25512,405,180
4.99+0.39+8.5%4.9955.054.724,663,385
4.60-0.04-0.9%4.785.204.1011,640,937
4.64+0.08+1.8%4.6054.754.4851,905,918
4.56+0.05+1.1%4.594.704.363,036,452
4.51+0.41+10.0%4.1954.7154.126,809,048
4.10-0.83-16.8%5.105.174.1013,655,594
Ticker
gettex:5VB
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
gettex
Currency
EUR

What changed lately

Latest news

All Nykode Therapeutics ASA news

Nykode Therapeutics ASA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
12 in the last 12 months · 12 in all · newest Aug 20, 2026 · oldest 2026
Calls
11 calls with a replay · 11 with a transcript · latest Aug 26, 2026
Decks
54 decks · latest Sep 16, 2026

Where Nykode Therapeutics ASA is listed

ListingExchangeCountryCurrency
Oslo:NYKD · Home listingOsloNorwayNOK
Aquis:NYKDOAquisUnited KingdomNOK
OTC:VACBFOTCUnited StatesUSD
gettex:5VB · This pagegettexGermanyEUR
Stockholm:NYKDOStockholmSwedenNOK
Lang & Schwarz:A2PZ5JLang & SchwarzGermanyEUR
LS Exchange:A2PZ5JLS ExchangeGermanyEUR
Stuttgart:5VBStuttgartGermanyEUR
Turquoise:NYKDOTurquoiseUnited KingdomNOK
Aquis:NYKDOAquisUnited KingdomNOK
Dusseldorf:5VBDusseldorfGermanyEUR
Frankfurt:5VBFrankfurtGermanyEUR
Munich:5VBMunichGermanyEUR

Valuation

Price/book 1.3× against a median of 3.0×: 2nd lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
606.8M NOK
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
1.3×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Nykode Therapeutics ASA · OSL:NYKDUS$107.0MUS$62.24Mn/an/an/a1.3×n/a0.0×n/a
OnKure Therapeutics, Inc. · NASDAQ:OKURUS$109.4M−US$53.16Mn/an/an/a0.7×n/a0.0×1.17
Spruce Biosciences, Inc. · NASDAQ:SPRBUS$109.2MUS$41.00Mn/an/an/a1.6×n/a0.3×1.73
NIBEC Co., Ltd. · KRX:138610US$108.7MUS$92.50Mn/a5.5×118×3.0×−0.1%0.0×n/a
Jyong Biotech Ltd. · NASDAQ:MENSUS$107.6MUS$125.0Mn/an/an/an/an/an/a1.74
JW (Cayman) Therapeutics Co. Ltd. · HKEX:2126US$105.3MUS$84.72Mn/a2.0×n/a1.6×−195.8%0.6×n/a
Genelux Corporation · NASDAQ:GNLXUS$104.3MUS$93.85Mn/a11,732×n/a11.4×n/a0.0×1.52
Cardiol Therapeutics Inc. Class A · TSX:CRDLUS$103.4MUS$83.06Mn/an/an/a5.4×n/a0.0×1.45
Heidelberg Pharma AG · XETR:HPHAUS$103.2MUS$81.75Mn/a8.0×n/an/a−320.9%n/an/a
Foghorn Therapeutics Inc. · NASDAQ:FHTXUS$103.1M−US$9.22M10.9×−0.1×−2.5×n/a8.4%n/a1.57
Vivani Medical, Inc. · NASDAQ:VANIUS$102.8MUS$88.24Mn/an/an/a7.8×n/a0.0×0.93
Median of the othersUS$104.8MUS$83.89M10.9×5.5×57.5×3.0×−97.9%0.0×1.52

Forecasts

Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
7.50 NOK · Analysts' mean
EPS, year to Dec 2026
-0.75 · 2 analysts
Revenue, year to Dec 2026
928K · 3 analysts

Team and board

Officers

OfficerRole
Michael EngsigChief Executive Officer
Harald GurvinChief Financial Officer
Louise StubbeChief Legal Officer
Agnete B. FredriksenChief Scientific Officer & Business Development
Jakob Helding RasmussenChief Technology Officer

Board

DirectorRole
Barbara Krebs-PohlChair of the Board
Christian ÅbyholmBoard Member
John BeadleBoard Member
Susanne StuffersBoard Member
Trygve LauvdalBoard Member

Events

Next results
Nov 23, 2026 (expected)

Results days

QuarterResultsShare move
Q2 2026Aug 26, 2026 · Before open−0.9%
Q1 2026May 27, 2026 · Before open−6.4%
Q4 2025Feb 25, 2026 · Before open−9.7%
Q3 2025Nov 23, 2025 · After close+3.6%
Q2 2025Aug 27, 2025 · Before open−9.8%
Q1 2025May 27, 2025 · After close−1.1%
Q4 2024Feb 26, 2025 · Before open+1.4%
Q3 2024Nov 26, 2024 · After close+5.0%
Q2 2024Aug 21, 2024 · Before open−47.0%
Q1 2024May 14, 2024 · Before open+2.1%
All 20 quarters
QuarterResultsShare move
Q4 2023Feb 28, 2024 · Before open−5.8%
Q3 2023Nov 15, 2023 · After close+1.1%
Q2 2023Aug 22, 2023 · After close−0.2%
Q1 2023May 12, 2023 · Before open+5.7%
Q4 2022Feb 28, 2023 · Before open−2.5%
Q3 2022Nov 23, 2022 · Before open−1.8%
Q2 2022Aug 24, 2022 · Before open+0.5%
Q1 2022May 16, 2022 · Before open−4.4%
Q3 2021Nov 17, 2021 · Before open−0.9%
Quarter to Jun 30, 2021Aug 26, 2021 · Before open−4.9%

Open Events

Decks

DeckKindSlidesDate
H.C. Wainwright 28th Annual Global Investment Conference 2026Conference27 slidesSep 16, 2026
Q2 2026 Earnings PresentationEarnings28 slidesAug 26, 2026
Investor Presentation (August 2026)Investor deck73 slidesAugust 2026
Q1 2026 Earnings PresentationEarnings27 slidesMay 27, 2026
Q1 2026 Earnings PresentationEarnings67 slidesMay 27, 2026
DNB Carnegie's Nordic Healthcare Conference 2026Conference32 slidesMar 10, 2026
Q4 2025 Earnings PresentationEarnings31 slidesFeb 25, 2026
Q4 2025 Earnings PresentationEarnings27 slidesFeb 25, 2026
Investor Presentation (January 2026)Investor deck93 slidesJanuary 2026
Investor Presentation (December 2025)Investor deck93 slidesDecember 2025
All 54 decks
DeckKindSlidesDate
DNB Nordic Healthcare Conference 2025Conference35 slidesNov 25, 2025
Q3 2025 Earnings PresentationEarnings35 slidesNov 24, 2025
HCW Annual Global Investment Conference 2025Conference33 slidesSep 10, 2025
Q2 2025 Earnings PresentationEarnings32 slidesAug 27, 2025
Q1 2025 Earnings PresentationEarnings24 slidesMay 28, 2025
Q4 2024 Earnings PresentationEarnings24 slidesFeb 26, 2025
Q3 2024 Earnings PresentationEarnings23 slidesNov 27, 2024
Investor Presentation (October 2024)Investor deck77 slidesOct 1, 2024
Investor Presentation (September 2024)Investor deck77 slidesSeptember 2024
Q2 2024 Earnings PresentationEarnings28 slidesAug 21, 2024
ABGSC Seminar - Autoimmunity, Transplantation & Inflammation 2024Conference14 slidesJun 11, 2024
Q1 2024 Earnings PresentationEarnings28 slidesMay 14, 2024
Investor Presentation (May 2024)Investor deck79 slidesMay 2024
Investor Presentation (April 2024)Investor deck77 slidesApril 2024
Investor Presentation (March 2024)Investor deck78 slidesMarch 2024
Q4 2023 Earnings PresentationEarnings23 slidesFeb 28, 2024
JPM Healthcare Conference 2024Conference35 slidesJan 10, 2024
DNB Nordic Healthcare Conference 2023Conference29 slidesDec 14, 2023
Investor Presentation (December 2023)Investor deck75 slidesDecember 2023
Jefferies Healthcare Conference London 2023Conference28 slidesNov 16, 2023
Q3 2023 Earnings PresentationEarnings27 slidesNov 15, 2023
Investor Presentation (November 2023)Investor deck72 slidesNovember 2023
mRNA Cancer Vaccine Summit 2023Conference30 slidesOct 12, 2023
Investor Day (September 2023)Investor day91 slidesSep 27, 2023
Investor Day (September 2023)Investor day110 slidesSep 20, 2023
Investor Presentation (September 2023)Investor deck46 slidesSeptember 2023
Q2 2023 Earnings PresentationEarnings21 slidesAug 23, 2023
Q1 2023 Earnings PresentationEarnings37 slidesMay 2023
Technical Presentation (April 2023)Technical38 slidesApr 19, 2023
Technical Presentation (April 2023)Technical37 slidesApr 18, 2023
Q4 2022 Earnings PresentationEarnings31 slidesFeb 28, 2023
41st Annual J.P. Morgan Healthcare Conference (January 2023)Conference35 slidesJan 9, 2023
Technical Presentation (December 2022)Technical20 slidesDec 20, 2022
Q3 2022 Earnings PresentationEarnings37 slidesNov 23, 2022
Technical Presentation (September 2022)Technical16 slidesSep 27, 2022
H1 2022 Earnings PresentationEarnings31 slidesAug 24, 2022
Investor Day (May 2022)Investor day79 slidesMay 12, 2022
Kempen Life Sciences Conference 2022Conference27 slidesApr 20, 2022
FY2021 Earnings PresentationEarnings32 slidesApr 1, 2022
Corporate Update (November 2021)Corporate update20 slidesNov 23, 2021

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue08.68M12.9M7.17M34.0M215.0M12.4M12.0M9.76M24.0K
Gross profit8.68M12.9M7.17M34.0M215.0M12.4M12.0M9.76M
Research and development13.4M14.7M29.4M26.8M16.3M10.6M60.8M
Selling, general and administrative13.6M4.34M6.28M8.89M9.28M8.56M6.08M2.32M1.60M841.5K
Operating income-28.6M-48.3M-58.1M-53.2M-10.8M178.3M-122.4M-65.8M-34.0M-1.62M
Depreciation and amortization2.04M743.0K629.0K1.81M734.0K304.0K1.40M58.0K58.0K8.31K
EBITDA-26.5M-47.6M-57.5M-51.3M-10.0M178.6M-121.0M-65.8M-33.9M-1.61M
Interest expense125.0K6.18M4.68M241.0K130.0K46.0K24.0K9.20K00
Income before tax-17.7M-45.5M-44.1M-51.0M-11.1M180.9M-120.2M-63.8M-31.4M-1.60M
Income tax-6.69M-8.93M-8.24M-1.70M31.1M
Net income-12.2M-38.8M-35.2M-42.7M-9.41M149.8M-120.2M-63.8M-31.4M-1.60M
Earnings per share, basic-0.04-0.12-0.12-0.14-0.040.51-0.41-0.26-0.13-0.03
Earnings per share, diluted-0.12-0.12

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents60.3M115.4M162.6M205.8M215.8M183.4M89.2M3.63M3.80M2.87M
Short-term investments012.2M24.9M190.3M143.6M206.4M
Receivables386.0K03.81M25.3M19.7M8.78K8.31M6.96M
Current assets61.9M117.1M165.7M211.9M255.9M229.0M291.2M152.9M214.0M24.9M
Property, plant and equipment5.68M3.74M4.41M9.53M9.16M408.0K173.0K110.0K89.2K9.60K
Total assets100.0M153.5M208.2M221.5M265.6M230.0M293.1M153.3M214.5M24.9M
Accounts payable4.07M3.68M7.06M2.31M2.75M1.61M13.4M5.52M6.08M
Current liabilities6.19M9.10M20.6M39.0M31.4M13.2M37.9M13.3M10.9M1.74M
Total debt3.44M5.73M5.51M7.17M284.0K790.1K
Total liabilities8.42M17.3M36.9M64.5M71.5M51.2M50.5M13.3M10.9M1.74M
Shareholders' equity91.5M136.2M171.3M157.0M194.1M178.8M242.6M140.1M203.5M23.2M
Shares outstanding326.5M323.5M300.5M301.5M264.3M292.6M292.8M242.4M241.8M55.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-29.5M-51.2M-96.6M-20.7M1.16M180.3M-92.1M-62.8M-62.8M-1.60M
Capital spending-38.0K-71.0K-1.90M-2.67M-871.0K-99.0K-667.2K-79.0K-79.0K-6.43K
Free cash flow-29.5M-51.3M-98.5M-23.4M284.0K180.2M-92.7M-62.9M-62.9M-1.61M
Cash from investing3.52M6.93M7.04M11.1M10.8M-6.02M-79.5M-79.0K-79.0K28.9K
Cash from financing-33.6M-1.40M44.6M360.0K20.4M-290.0K227.1M337.0K337.0K2.35M
Dividends paid-32.3M
Share buybacks045.7M1.80M21.2M026.0M37.5K23.3M2.37M
Change in cash-55.1M-45.7M-45.0M-9.85M32.4M173.7M-55.3M144.5M-62.5M782.8K

Open Financials

Cap table

Built by 6ix from Nykode Therapeutics ASA’s releases

Common shares
391,546,444
Fully diluted
391,546,444

Fully diluted

LineShares
Common shares391,546,444

Share count over time

CountShares
Nov 22, 2026391,546,444

Open Cap table

Shareholders

HolderSharesValueAs of
SMALLCAP World Fund Inc17MUS$5.55MJun 30, 2026
SMALLCAP World Fund489KUS$159KJun 30, 2026
The Continental Small Company Series443KUS$158KJul 31, 2026
Dimensional International Core Equity 2 ETF135KUS$48,135Jul 31, 2026
Dimensional International Small Cap ETF78,627US$28,021Jul 31, 2026
International Social Core Equity Portfolio64,735US$23,130Jul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF46,612US$16,612Jul 31, 2026
International Sustainability Core 1 Portfolio42,265US$15,101Jul 31, 2026
International Vector Equity Portfolio38,010US$13,581Jul 31, 2026
State Street(R) SPDR(R) Portfolio Europe ETF8,301US$2,701Jun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Agnete B. FredriksenChief Scientific Officer & Business Development · Since at least Aug 20, 2026
Barbara Krebs-PohlChair of the Board · Since at least May 27, 2026
Christian ÅbyholmBoard Member · Since at least May 27, 2026
Harald GurvinChief Financial Officer · Since at least May 27, 2026
Jakob Helding RasmussenChief Technology Officer · Since at least Nov 5, 2026
John BeadleBoard Member · Since at least May 27, 2026
Louise StubbeChief Legal Officer · Since at least Nov 5, 2026
Michael EngsigChief Executive Officer · Since at least Aug 20, 2026
Susanne StuffersBoard Member · Since at least May 27, 2026
Trygve LauvdalBoard Member · Since at least May 27, 2026

Open People

Log in to ask 6ix AI your own questions about Nykode Therapeutics ASA.